Biological scientists lead main research study that aims to create drugs more effective University of Southampton biological researchers are leading a significant research project targeted at making drugs far better. They are investigating several proteins known as 'multidrug transporters', which remove undesirable and toxic materials from cells. These proteins safeguard cells from toxins Normally, but multidrug transporters prevent anticancer medications from killing cancers cells also, particularly because the amount of the proteins is elevated in cancer cells if they encounter such medications cafergot.net http://cafergot.net . Related proteins also remove antibiotics from bacterias and remove herbicides from the plant cells of weeds resulting in herbicide resistant weeds.
, a worldwide biotechnology innovator in the discovery, advancement, commercialization and manufacturing of innovative therapies, announced its full 12 months and fourth quarter 2011 results today.0 billion year-over-year.7 billion.0 billion for the full year, a loss of 7 percent versus prior year because of certain royalties from individual countries expiring and a charge of around $50 million from an accrual associated with Genentech’s arbitration with Hoechst GmbH. Global in-market product sales of TYSABRI for the entire season of 2011 were $1.5 billion, a rise of 23 percent over 2010. The full total was made up of $747 million in U.S.